Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine
About this webinar
Using real-world data is vital for commercialization efforts to increase therapy adoption and return on investment. Provider identification and segmentation is crucial to inform a targeted marketing strategy that delivers the right message to the right provider at the right time.
This webinar will demonstrate how leveraging real-world data can accurately identify provider with treatment-eligible patients early in their healthcare journey. It will also highlight strategies for segmenting providers to optimize field force planning.
The expert speaker will also highlight how applied scoring methods based on provider testing and treatment behaviors can inform engagement plans.
Register for this webinar today to discover how leveraging real-world data can enhance the commercialization strategy, increase therapy adoption and help identify provider with treatment-eligible patients.
Who should attend
- Head of Global Business/Market Analytics/Precision Medicine
- Advanced Analytics
- Director, Commercial Insights and Operations
- US Commercial Head/Lead
- Vice President, Precision Medicine/Clinical Trial Strategy & Operations
- Vice President, Insights & Analytics
- HCP Marketing
- Marketing and Market Access teams
- Pharmaceutical Sales
- Brand Lead Managers
- Commercial Data Science
What you will learn
- How precision medicines require a shift from a traditional launch strategy
- How daily lab result data can identify providers with therapy eligible patients during the treatment decision window and increase field team efficiencies
- How real-world data can be used to assess and score providers based on testing and treatment behaviors to determine the right engagement strategy at the right time.
Featured Speakers
Kelly Williams, MBA, BSN, RN
Kelly Williams has dedicated her entire career to ensuring that patients receive the right treatments at the right time. She has worked as a registered nurse, a consultant in Deloitte’s Healthcare and Life Sciences practice and in customer success and partnership roles at real-world data (RWD) companies. Over her more than 20 year career, Kelly has leveraged her clinical knowledge and physician engagement experience to help customers maximize the value of their data.
As Vice President of Insight Solutions at Diaceutics PLC, Kelly leads her team in helping global pharmaceutical and biotech companies enhance their commercial strategies through the use of real-world data (RWD) and insights. She brings extensive experience in standardizing care, physician engagement, precision medicine and data analytics. Kelly’s deep understanding of industry challenges and the potential of RWD enables her to deliver innovative solutions that drive commercial success and ROI for her customers.
Partner for this event
Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by the proprietary DXRX platform.
DXRX is the world’s first diagnostic commercialisation platform for precision medicine, utilising a global network of affiliate laboratories to deliver multiple pipelines of real-world healthcare data insights, advisory services and innovative platform-enabled solutions.
Related webinars
More from Diaceutics.
Complexity to Clarity: Using Multi-Modal Data To Drive Commercial Success
Accelerate Precision Medicine Uptake With Impactful Scientific Engagement
Optimize Your Physician Engagement Strategy: Data-Driven HCP Education in Precision Medicine
Driving Commercial Success for Precision Medicine: Understand the Market to Maximize Patient Identification and Therapy Adoption